Table 2. Estimates of proportions of children younger than 5 years with a fever and Plasmodium falciparum infection who received an ACT in sub-Saharan countries in 2015.

	Children <5 years with fever and infection who received an ACT
Test positivity
RDT positive	197% (15.6–24.8)
RDT negative	16.3% (13.4–19.4)
Residence
Rural	197% (15.4–25.4)
Urban	18.9% (9.9–31.3)
Socioeconomic status
Poorer (<median wealth)	18.8% (14.4–24.8)
Wealthier (>median wealth)	21.2% (14.8–29.7)
Endemicity
Hypoendemic	16.9% (8.3–30.6)
Mesoendemic	19.8% (15.9–24.6)
Hyperendemic or holoendemic	19.0% (9.9–35.3)
Treatment seeking
Did seek care	25.9% (20.1–33.4)
Did not seek care	8.3% (5.2–13.0)
Health-care provider
Private	18.7% (11.5–28.3)
Public	30.6% (22.8–41.2)

Estimates are mean (95% CI) and are for children younger than 5 years with a fever and an infection (RDT positive), apart from the test positivity data, which is for all children younger than 5 years with a fever. Data were calculated excluding those countries with a mean Plasmodium falciparum prevalence in children aged 2–10 years of less than 2%: Botswana, Djibouti, Eritrea, Ethiopia, South Africa, and Swaziland. Estimates were adjusted by the population at risk for each stratum. ACT=artemisinin-based combination therapy. RDT=rapid diagnostic test.